The document Recommendation Paper on Frequent Issues Identified during Assessment of Part I and Part II” has been published in Eudralex Volume 10

This paper summarises the most common comments and observations raised by Member States and Ethics Committees during the assessment of clinical trial applications. It also provides recommendations from the EC (European Commission) and EMA (European Medicines Agency) to sponsors and their representatives to help prevent similar issues in future submissions.